HTB

IAS 8 Vancouver 2015

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19-22 July 2015, Vancouver, Canada

The PrEP experience: IAS 2015 and beyond

News and notes on HIV cure research from IAS 2015

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19 – 22 July 2015, Vancouver, Canada

Tribute to Bob Munk: long-time HIV positive US treatment activist and educator

Four reasons IAS 2015 will be a milestone HIV conference: a personal view

Starting HIV treatment at high CD4 counts protects against both AIDS and non-AIDS events: overall and in subgroup analyses of START study

The option for same day antiretroviral therapy on diagnosis: the future model for HIV care

Pipeline ARVs at IAS 2015: doravirine, BMS-955176 and BMS-663068

New directions in the 2015 WHO ART guidelines

Rapid implementation of the 2013 WHO ART guidelines

Large variation across countries in meeting UNAIDS 90-90-90 targets

Low dose boosted atazanavir is non-inferior to standard dose in Thai treatment optimisation study: LASA

HPTN 052: no HIV transmissions on effective ART but only limited data on viral failure and drug resistance

Dispersible tablet formulation of dolutegravir is bioequivalent to the granule formulation

New case of remission in a perinatally infected teenager

IAS 2015: accessing webcasts and abstracts online